Announce Date | 05/02/2024 |
EPS Normalized Actual | $0.55 (Beat by $4.14) |
EPS GAAP Actual | $0.55 (Beat by $4.14) |
Revenue Actual | $6.066B |
Revenue Surprise | Beat by $6066M |
Announce Date | 06/30/2024 (Pre-Market) |
EPS Normalized Estimate | $1.33835 |
EPS GAAP Estimate | $1.33835 |
Revenue Estimate | $3.20425B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 14.666 | 8.38 | 11.08621 | 19.20441 | 7 |
Dec 2027 | 3.00324 | 40.9 | 2.27019 | 3.9326 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 9.09 | 9.09 | 6.066B | 68.07% | 6066M |
FQ4 2021 (Dec 2021) | 12.03 | 12.03 | 7.211B | 92.09% | 7211M |
FQ3 2021 (Sep 2021) | 8.27 | 8.27 | 4.969B | 96.82% | 4969M |
FQ2 2021 (Jun 2021) | 6.93 | 6.93 | 4.354B | 98.48% | 4354M |
FQ1 2021 (Mar 2021) | 3.05 | 3.05 | 1.937B | 99.57% | 1937M |
FQ4 2020 (Dec 2020) | -0.69 | -0.69 | 0.570745B | 97.54% | 570.75M |
FQ3 2020 (Sep 2020) | -0.59 | -0.59 | 0.15791B | 89.21% | 157.91M |
FQ2 2020 (Jun 2020) | -0.31 | -0.31 | 0.066351B | 80.28% | 66.35M |
FQ4 Announce Date
06/30/2024 (Pre-Market)
Consensus EPS Estimates
1.33835
Consensus Revenue Estimates
3.20425B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 1.7809 | -- | 0.55294 | 2.60566 | 5 |
FQ3 2026 (Jul 2026) | -2.7373 | -- | -4.00499 | -0.84988 | 5 |
FQ1 2026 (Mar 2026) | -2.6996 | -- | -3.94983 | -0.83817 | 11 |
FQ4 2025 (Oct 2025) | -0.51023 | -- | -0.74653 | -0.15842 | 11 |
FQ3 2025 (Jul 2025) | -2.78108 | -- | -4.06904 | -0.86347 | 10 |
FQ2 2025 (Jun 2025) | -2.71443 | -- | -13.07914 | 0.44894 | 6 |
FQ1 2025 (Mar 2025) | -2.54878 | -- | -12.28097 | 0.42155 | 6 |
FQ4 2024 (Oct 2024) | -1.12396 | -- | -1.9201 | 0.19669 | 13 |
FQ3 2024 (Jul 2024) | -3.40993 | -- | -4.16554 | -2.82869 | 13 |
FQ2 2024 (Jun 2024) | 1.33835 | -- | -0.66462 | 4.46117 | 13 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 3.19B | -- | 1.5B | 4.33B | 10 |
FQ3 2026 (Jul 2026) | 0.32B | -- | 0.15B | 0.43B | 10 |
FQ1 2026 (Mar 2026) | 0.35B | -- | 0.16B | 0.47B | 10 |
FQ4 2025 (Oct 2025) | 1.71B | -- | 0.8B | 2.32B | 5 |
FQ3 2025 (Jul 2025) | 0.37B | -- | 0.18B | 0.51B | 5 |
FQ2 2025 (Jun 2025) | 0.5B | -- | 0.05B | 1.98B | 4 |
FQ1 2025 (Mar 2025) | 0.63B | -- | 0.07B | 2.49B | 4 |
FQ4 2024 (Oct 2024) | 1.49B | -- | 0.96B | 1.91B | 12 |
FQ3 2024 (Jul 2024) | 0.12B | -- | 0.07B | 0.18B | 11 |
FQ2 2024 (Jun 2024) | 3.2B | -- | 2.57B | 3.82B | 18 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 9.09 | 9.09 | 100% | |
FQ4 2021 (Dec 2021) | 12.03 | 12.03 | 100% | |
FQ3 2021 (Sep 2021) | 8.27 | 8.27 | 100% | |
FQ2 2021 (Jun 2021) | 6.93 | 6.93 | 100% | |
FQ1 2021 (Mar 2021) | 3.05 | 3.05 | 100% | |
FQ4 2020 (Dec 2020) | -0.69 | -0.69 | 100% | |
FQ3 2020 (Sep 2020) | -0.59 | -0.59 | 100% | |
FQ2 2020 (Jun 2020) | -0.31 | -0.31 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $6.07B | $6066M | 100% |
FQ4 2021 (Dec 2021) | $0B | $7.21B | $7211M | 100% |
FQ3 2021 (Sep 2021) | $0B | $4.97B | $4969M | 100% |
FQ2 2021 (Jun 2021) | $0B | $4.35B | $4354M | 100% |
FQ1 2021 (Mar 2021) | $0B | $1.94B | $1937M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.57B | $570.75M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.16B | $157.91M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.07B | $66.35M | 100% |